FdaApplication
ANDA 211713
Identifiers
- fda_app_no: ANDA211713
Properties
| Property | Value |
|---|---|
| applicant_name | XELLIA PHARMACEUTICALS APS |
| application_type | ANDA |
| approval_date | 2021-06-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 50MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
| MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 100MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
2 products